Literature DB >> 6822201

Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds.

R Podbesek, C Edouard, P J Meunier, J A Parsons, J Reeve, R W Stevenson, J M Zanelli.   

Abstract

The adult greyhound was found to be similar to adult man with respect to kinetic and histomorphometric indices of calcium metabolism. The relationship between trabecular bone tissue balance and the pattern of human PTH fragment 1-34 (hPTH 1-34) administration by daily injections or continuous sc infusions was investigated in this model and the results compared to those from a clinical trial of hPTH 1-34 in involutional osteoporosis (peptide administration by single daily injections). In the dogs, the daily injection regime elevated plasma levels of immunoreactive hPTH 1-34 for no more than 4 h/day. The greyhounds so treated showed significantly increased indices of bone formation (surface osteoid, plasma alkaline phosphatase activity, and skeletal accretion rate of calcium) and resorption (number of osteoclasts, resorption surfaces). Iliac trabecular bone volume increased significantly, as it did in the patients. The infusions did not significantly increase the trabecular bone volume or the 47Ca accretion rate, two parameters which increased in parallel in dogs and patients treated successfully by daily injections. The osteoclastic surfaces, however, were clearly increased by continuous infusions, while the increases in the osteoblastic surfaces were less statistically significant. Since hPTH 1-34 may inhibit osteogenesis in Friedenstein chambers, it is possible that the increased osteoblastic activity induced by the daily injection regime in trabecular bone is dependent on the noncontinuous nature of the PTH stimulus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6822201     DOI: 10.1210/endo-112-3-1000

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  28 in total

1.  2011 AOA Symposium: Tissue Engineering and Tissue Regeneration: AOA critical issues.

Authors:  Scott A Rodeo; Scott D Boden; Martha M Murray; Thomas A Einhorn
Journal:  J Bone Joint Surg Am       Date:  2013-08-07       Impact factor: 5.284

2.  Parathyroid hormone modulates transforming growth factor beta activity and binding in osteoblast-enriched cell cultures from fetal rat parietal bone.

Authors:  M Centrella; T L McCarthy; E Canalis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

Review 3.  Parathyroid hormone in the treatment of involutional osteoporosis: back to the future.

Authors:  J Y Reginster; A N Taquet; G Fraikin; C Gosset; B Zegels
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 4.  Biophysical regulation of stem cell differentiation.

Authors:  Peter M Govey; Alayna E Loiselle; Henry J Donahue
Journal:  Curr Osteoporos Rep       Date:  2013-06       Impact factor: 5.096

5.  Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.

Authors:  T Ishizuya; S Yokose; M Hori; T Noda; T Suda; S Yoshiki; A Yamaguchi
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

6.  Human parathyroid hormone (1-34) and salmon calcitonin do not reverse impaired mineralization produced by high doses of 1,25 dihydroxyvitamin D3.

Authors:  M Gunness-Hey; J M Hock; I Gera; J Fonseca; J Poser; J Bevan; L G Raisz
Journal:  Calcif Tissue Int       Date:  1986-04       Impact factor: 4.333

7.  Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol.

Authors:  M Neer; D M Slovik; M Daly; T Potts; S R Nussbaum
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

8.  A new model of osteopenia using ectopically induced bone: effects of parathyroid hormone and estradiol on bone turnover in induced bone.

Authors:  J Hashimoto; K Takaoka; H Yoshikawa; S Miyamoto; S Suzuki; K Ono
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

9.  Stimulation of creatine kinase activity in rat skeletal tissue in vivo and in vitro by protease-resistant variants of parathyroid hormone fragments.

Authors:  D Sömjen; V Vargas; A Waisman; E Wingender; W Tegge; A M Kaye
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

10.  Full length parathyroid hormone (1-84) in the treatment of osteoporosis in postmenopausal women.

Authors:  Esteban Jódar-Gimeno
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.